Andrew Atkinson, PhD
Assistant Professor of Medicine
Dr. Atkinson is a biostatistician providing project-based and ad hoc consultancy in the division. His methodological research includes developing methods for handling missing data in clinical trials and for observational data, novel clinical trial design methods, trial emulation and Bayesian modelling. Dr. Atkinson has a joint appointment with the Center for Biostatistics and Data Science.
Dr. Atkinson has primarily been involved with projects concerned with infectious diseases (HIV, hospital epidemiology, COVID), but also has experience with pediatric projects. He has a PhD in Biostatistics (London School of Hygiene and Tropical Medicine, University of London), focused on developing methods for investigating informative missingness in time to event analysis using multiple imputation.
- BSc in Mathematics, School of Mathematics, University of East Anglia, UK (1991)
- Erasmus Scholarship, Mathematics Institute, Albert-Ludwigs-University, Freiburg-im-Breisgau, Germany (1989-1990)
- MSc in Statistics, School of Mathematics and Statistics, University of Sheffield, UK (2009)
- PhD, Biostatistics: “Reference Based Sensitivity Analysis for Time-to-Event Data”, Medical Statistics Dept, London School of Hygiene and Tropical Medicine, University of London, UK (2018)
- 2019-20 Swiss National Science Foundation “A Precision Medicine Approach for Innovative Outbreak Investigation using Machine Learning Methods” (PI, grant #CRSK-3_190977/1)
- 2018-22 Swiss National Science Foundation “Understanding the drivers of surgical site infection: Investigating and modeling the Swissnoso surveillance data” (project partner, grant #32003B_179500)
1. Widmer AF, Atkinson A, Kuster SP, et al. Povidone Iodine vs Chlorhexidine Gluconate in Alcohol for Preoperative Skin Antisepsis: A Randomized Clinical Trial. JAMA. Published online June 17, 2024. doi:10.1001/jama.2024.8531
2. Atkinson A, Zwahlen M, Barger D, et al. Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE. Clin Infect Dis. 2021 Jul 15;73(2):195-202. doi: 10.1093/cid/ciaa615.
3. Atkinson A, Kenward MG, Clayton T, Carpenter JR. Reference-based sensitivity analysis for time-to-event data. Pharm Stat. 2019 Nov;18(6):645-658. doi: 10.1002/pst.1954.